A core outcome set for localised prostate cancer effectiveness trials.
Steven MaclennanPaula R WilliamsonHanneke BekemaMarion CampbellCraig RamsayJames N'DowSara MacLennanLuke ValePhilipp DahmNicolas MottetThomas Lamnull nullPublished in: BJU international (2017)
We have established a COS for trials of effectiveness in localised prostate cancer, applicable across all interventions that should be measured in all localised prostate cancer effectiveness trials.